Background: Few nomograms can predict overall survival (OS) after curative resection of advanced gastric cancer (AGC), and these nomograms were developed using data from only a few large centers over a long time period. The aim of this study was to develop and externally validate an elaborative nomogram that predicts 5-year OS after curative resection for serosanegative, locally AGC using a large amount of data from multiple centers in Japan over a short time period (2001)(2002)(2003). Results: Age at operation, gender, tumor size and location, macroscopic type, histological type, depth of invasion, number of positive and examined lymph nodes, and lymphovascular invasion, but not the extent of lymphadenectomy, were associated with OS. Discrimination of the developed nomogram was superior to that of the TNM classification (concordance indices of 0.68 versus 0.61; P < 0.001). Moreover, calibration was accurate.
introduction
Gastric cancer was the second leading cause of cancer death in both sexes worldwide in 2008 (736 000 deaths, 9.7% of the total) [1] . In Japan, 49 830 people died of gastric cancer in 2011, ranking gastric cancer second among all cancer deaths [2] . The prognosis of gastric cancer greatly differs according to the spread or characteristics of the tumor. The identification of prognostic factors of gastric cancer is useful for clinical decision-making and improved survival rates [3] .
The American Joint Committee on Cancer (AJCC) classified gastric cancer into nine groups in the seventh edition of their classification system [4] . The classification is based on the depth of invasion, number of metastatic lymph nodes, and metastasis. This system represents an excellent common language in the field of gastric cancer, but it does not include other prognostic factors such as age, tumor size, or other tumor characteristics [3, [5] [6] [7] [8] [9] .
A nomogram is a useful tool that predicts the probability of a clinical event via a simple, clear figure and is widely used in the field of cancer [10] . A few good nomograms that predict the survival rate or recurrence of gastric cancer have been developed [11] [12] [13] . However, most nomograms of gastric cancer were developed using data from only a few large centers over a long time period (from the 1980s to 2000s); such a long time period introduces external variations in long-term outcomes [14] .
The aim of this study was to develop and externally validate a more elaborative nomogram that predicts 5-year overall survival (OS) in patients who have undergone curative resection with a high probability of cure (namely, Resection A) for serosa-negative, locally advanced gastric cancer (AGC). We obtained data from multiple centers in Japan during a short time period (2001) (2002) (2003) . This short time period enables us to reduce bias that arises from variation in survival outcomes between centers and during different time periods. We selected patients with serosa-negative, locally AGC who underwent Resection A, because such patients were considered to have a better prognosis and might benefit more from adjuvant therapy than would other patient populations. We expected that this nomogram could contribute to the selection of good candidates for adjuvant therapy. For the analysis, we adopted a wide variety of factors regarded as prognostic factors to enhance the accuracy of prediction [3, [5] [6] [7] [8] [9] .
patients and methods 
factors
The definition and documentation of factors were based on the Japanese Classification of Gastric Carcinoma, 13th edition [15] . To predict the probability of 5-year OS, we used the following variables: age at operation, gender, tumor size, main tumor location (upper third, middle third, or lower third), macroscopic type, histological type, depth of invasion, number of positive lymph nodes, number of examined lymph nodes, lymphovascular invasion, and extent of lymphadenectomy.
The macroscopic types were classified into six categories. Types 1-4 were equivalent to the Borrmann classification. Type 0 indicated superficial, flat tumors with or without minimal elevation or depression, and type 5 indicated unclassifiable carcinomas that could not be classified into any of the above types.
The histological types were classified into six categories: mucinous adenocarcinoma; tubular adenocarcinoma; poorly differentiated adenocarcinoma, solid type; poorly differentiated adenocarcinoma, nonsolid type; signet-ring cell carcinoma; and papillary adenocarcinoma. Considering the fact that poorly differentiated adenocarcinoma, nonsolid type and signet-ring cell carcinoma often coexisted in the resected specimens, we grouped these two histological types into one category for the multivariable analysis.
All curative resections in this study were Resection A. Resection A for AGC is defined by no residual disease, a high probability of cure, and satisfaction of all of the following conditions: (i) depth of invasion is the proper muscle or subserosa; (ii) N0 treated by D1 or more lymph node dissection or N1 treated by D2 or more lymph node dissection; (iii) no distant organ metastasis including on peritoneal wash cytology; and (iv) proximal and distal resection margins of >10 mm.
statistical analysis
OS was estimated using the Kaplan-Meier method. Cox proportional hazards regression was used for multivariable analysis. We adopted a piecewise linear hazards model to detect the cut points of continuous variables, because this model is more flexible than the ordinary linear regression model [16] . Cubic splines and fractional polynomials might be useful, but require the estimation of many parameters to construct models. Furthermore, it is known that the inclusion of unnecessary terms and parameters in hazard models leads to decreasing statistical powers of interesting risk factors. Therefore, we did not adopt them. Piecewise linear variables were generated from continuous variables. For example, seven piecewise linear variables <Age − i> (i = 30, 40, 50, 60, 70, 80, 90) were generated by age. If age was <i years, the piecewise linear variable <Age − i> represents 0. Otherwise, the variable <Age − i> represents age − i. In the same way, we generated <Size − i> (i = 2, 4, 6 … 24), <Positive lymph nodes − i> (i = 1, 2, 3 … 34), and <Examined lymph nodes − i> (i = 10, 20, 30 … 130). We conducted variable selection by means of the forward stepwise method using not only the original variables, but also the generated piecewise linear variables. We then developed a nomogram and Web software predicting OS after curative resection of AGC based on the results.
External validation of the nomogram was carried out by discrimination and calibration using the data of patients who had undergone surgery in 2003. Discrimination was evaluated by the concordance index (c-index), which estimates the probability of concordance between predicted and observed responses [17] . A value of 0.5 indicates no predictive discrimination, and a value of 1.0 indicates perfect separation of patients with different outcomes. The bootstrapping method was used to reduce estimate bias. Calibration was carried out by grouping all patients with respect to their nomogram-predicted OS by quartile and then comparing the mean of the group with the observed Kaplan-Meier estimate of actual OS.
All analyses were carried out using SPSS ver. 20 (IBM Corp., Armonk, NY) and R 2.14.1 software with Package Hmisc ver. 3.4-2. In all statistical analyses, a P-value of <0.05 was considered significant.
results
Descriptive statistics for the AGC cohort are listed in Table 1 . Variables to fit the Cox model were selected from all variables in Table 1 and the piecewise variables using the forward stepwise method (P < 0.05). Table 2 shows the results of the variable selection with hazard ratios and P-values. Age at operation, gender, tumor size, main tumor location, macroscopic type, histological type, depth of invasion, number of positive lymph nodes, number of examined lymph nodes, and lymphovascular invasion were statistically significant, whereas the extent of lymphadenectomy was not statistically significant. Some selected predictors included piecewise linear variables. We grouped macroscopic types 2 and 3 into one category to make the model fit on the basis of the Akaike Information Criterion value [18] . Interpretation of piecewise variables: for example for age, a hazard ratio of <60 years of age is regarded as a reference, and the hazard ratio becomes 1.07 times higher for every 1-year increase in age when the age of the patient is >60 years. For tumor size, a hazard ratio of <12 cm is a reference and the hazard ratio becomes 2.15 times higher for every 1-cm increase in tumor size from 12 to 14 cm. When the tumor size is >14 cm, the hazard ratio becomes 1.05 times (1.05 = 2.15 × 0.49) higher for every 1-cm increase in tumor size. The number of positive lymph nodes and the number of examined lymph nodes are interpreted in the same way. a Piecewise variable.
LNs, lymph nodes; muc, mucinous adenocarcinoma; tub, tubular adenocarcinoma; por1, poorly differentiated solid adenocarcinoma; por2, poorly differentiated nonsolid adenocarcinoma; sig, signet-ring cell carcinoma; pap, papillary adenocarcinoma. by drawing a line straight upward from each predictor to the point axis, and the total points are then calculated by summing each point. The probability of 2-year and 5-year OS can be found by drawing a line straight down from the total points axis. The nomogram was externally validated using the independent dataset listed in Table 1 . The c-index was 0.68 [95% confidence interval (CI) 0.66-0.71] in the external validation set. Furthermore, we compared the discrimination of our nomogram with that of the seventh AJCC TNM classification. The discrimination of our nomogram was superior to that of the seventh AJCC TNM classification (TNM classification c-index, 0.61; 95% CI 0.59-0.64).
Supplementary Figure S1 , available at Annals of Oncology online shows calibration plots for the AGC nomogram. The dashed line indicates the ideal line at which the nomogram-predicted probability equals the actual survival probability. In the 2-year OS graph, the dotted line indicates a 5% margin from the ideal line. In the 5-year OS graph, the dotted line indicates a 7.5% margin from the ideal line. Both calibrations were accurate, because the 95% CIs of the actual outcomes were within their margins.
Supplementary Figure S2 , available at Annals of Oncology online shows the Web software that predicts the probability of 1-year to 5-year OS and draws a survival curve (http://vps2. takatyan.info/surv/main.rb). These predictions can be calculated by entering clinicopathologic variables on the website. Nomogram predicting the probability of 2-year and 5-year overall survival of postoperative advanced gastric cancer. Each point can be determined by drawing a line straight upward from each predictor to the point axis. The total points are then calculated by summing each point. The probability of 2-year and 5-year overall survival can be found by drawing a line straight down from the total points axis.
AGC (5196) was the largest, and the time span of the dataset (3 years) was the shortest. This nomogram was more significantly predictive than the seventh AJCC stage grouping, with a c-index of 0.68 and good calibration. To avoid the complexity of drawing lines and adding points on the nomogram, we also constructed Web software that could be freely used. In this study, patients with serosa-negative, locally AGC were selected and mainly assigned to stage II according to the Japanese Classification of Gastric Carcinoma [15] . Compared with the 5-year OS rate of 73% after surgery alone for this patient population, adjuvant chemotherapy with uracil-tegafur significantly improved 5-year OS up to 86% in a randomized, controlled trial [19] . The Adjuvant Chemotherapy Trial of S-1 for Gastric Cancer, another randomized phase III trial with similar eligibility criteria, confirmed the effectiveness of 1-year postoperative treatment of S-1 compared with surgery alone in patients with stage II gastric cancer who underwent D2 gastrectomy, with the 5-year OS rate after surgery being 71.3% in the surgery-only group and 84.2% in the S-1 group [20] . However, whether all patients at this stage require adjuvant chemotherapy is uncertain. Our nomogram may be a useful tool to select patients who are unlikely to benefit from adjuvant chemotherapy. For example, adjuvant chemotherapy may be unnecessary if the predicted OS according to this nomogram is >85%.
Some variables that were not used in previous nomograms were selected as independent prognostic factors and entered into our nomogram. In serosa-negative, locally AGC, macroscopically advanced types (types 1, 2, 3, and 4) were more unfavorable than the macroscopically superficial type (type 0), which seemed to be an intuitively plausible and useful variable for the nomogram. The number of patients with type 4 tumors was extremely small, and the hazard ratio was unexpectedly low (1.73); this was probably because only patients whose depth of invasion was limited to the muscle proper or subserosa were included in this study. Unlike previous studies that use the Lauren classification [12] or simple grading by tumor differentiation [11] , histological type was selected as an independent prognostic factor in this study. When subclassified into five subtypes, poorly differentiated adenocarcinoma, nonsolid type including signet-ring cell histology, and papillary adenocarcinoma were significantly associated with poorer survival. It seemed strange that both a differentiated and an undifferentiated histology were simultaneously unfavorable prognostic factors; however, this might explain the reason why histological type was not selected as a significant prognostic factor in previous studies. Lymphovascular invasion was also selected as an independent prognostic factor in this study. Although it was not included in previous nomograms [11] [12] [13] , its influence on postoperative survival is known [6, 9] . Based on these results, the presence or absence of lymphovascular invasion was used in our nomogram. The results of other prognostic factors such as sex, number of positive and examined lymph nodes, and depth of invasion were consistent with those of previous nomograms. The significance of number of examined or negative lymph nodes was reaffirmed for prognosis.
The c-index of our nomogram was 0.68, slightly lower than those reported in previous studies (0.70-0.80 in different patient populations) [11] [12] [13] . It is unclear why the c-index of our nomogram was lower than others. One possible explanation is the difference in patient populations. Previous studies included many patients with early gastric cancer whose prognosis was excellent (22-65.1% of each patient population) [11, 12] . This study, on the other hand, included only patients with serosanegative, locally AGC whose prognoses varied widely. When patients with early gastric cancer were included in this study, the c-index of our nomogram was as high as 0.84 (data not shown). Our nomogram discrimination was superior to that of the AJCC stage grouping (0.68 versus 0.61, P < 0.001).
Our study accurately predicts survival. The calibration plot of the external validation set indicated that actual survival corresponded closely with predicted survival and was always within a 7.5% margin from the ideal reference line; this suggests that the nomogram was more predictive than that of Han et al. [11] . In addition, by using the JGCA nationwide registry, the data of 5196 patients over a 3-year period could be collected from various institutions. The average number of patients recruited in this study was 1732 per year, which is much higher than patient numbers in previous studies (45-361 patients per year) [11, 12] . The nomogram can be widely used because this data collection method may minimize the effect of patients' historical backgrounds and institutional differences.
There are some limitations to our study. First, our nomogram was developed and validated using data from almost exclusively Japanese patients with relatively less advanced disease. Therefore, it would be necessary for our nomogram to be externally validated by datasets in other countries for more widespread use, although disease stages of the datasets should be unified as in this study. Second, recent studies confirmed that adjuvant chemotherapy improved survival in patients with locally AGC [20, 21] . However, we could not evaluate the effect of adjuvant chemotherapy, because it was not common in this study period. Adjuvant chemotherapy should be added as a prognostic factor for nomograms in future studies.
conclusion
We have developed a nomogram and accompanying Web software that predict 5-year OS after curative resection for serosanegative, locally AGC. External validation demonstrated that calibration of the nomogram was accurate. This nomogram and Web software should be helpful for the clinical assessment of individual risks and the consideration of adjuvant therapy. Our Web software enables users to more easily and quickly predict OS and to draw a survival curve, without cumbersome procedures. Furthermore, we revealed that not only traditional variables used for previously reported nomograms, but also histological type, macroscopic type, and lymphovascular invasion were independent prognostic factors. We hope that this study will help other researchers to investigate the prognosis of gastric cancer and that the nomogram will be widely applied to predict survival of this disease in clinical practice.
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